Thus, targeting specificmechanistically linked Bcl-2 family cell death/survival factor pairs may represent a generalapproach to eliminate certain types of breast cancer cells representing different mammaryepithelial lineages within a given tumor (Figure 2). Here, BCL2 is linked to breast carcinoma.